Hofseth BioCare Posts Record Q3 Revenue on Ingredient Demand

Hofseth BioCare ASA (HBC) posted NOK 83.5 million in total operating revenues for the third quarter of 2026, its highest quarterly figure on record, up sharply from NOK 54.9 million in Q3 2025. Net operating revenues came in at NOK 82.1 million, compared to NOK 54.8 million in the year-prior period — a year-over-year increase of roughly 50%.

The Norwegian marine bioactive ingredient supplier specializes in upcycled salmon-derived ingredients, including protein hydrolysates, fish oil concentrates, and collagen peptides — categories that have seen sustained demand growth across functional food, dietary supplement, and clinical nutrition segments. The scale of the revenue jump suggests meaningful volume gains rather than price-driven uplift alone, though HBC has not disclosed unit pricing or volume detail in this preliminary report.

Supply-Chain Context

HBC's model centers on converting salmon processing byproducts from Norwegian aquaculture into high-specification ingredient streams, an approach that aligns with both clean-label sourcing narratives and circular-economy procurement priorities increasingly relevant to European and North American ingredient buyers. Marine collagen and omega-3-rich fish oil fractions from certified, traceable aquaculture sources carry meaningful specification advantages — including traceability documentation, COA support, and non-GMO positioning — that differentiate them from commodity alternatives in finished-product formulation.

For co-manufacturers and contract manufacturing operations sourcing marine peptides or omega-3 concentrates, supplier financial health is a practical procurement consideration: a supplier posting record revenues is typically one investing in capacity, quality systems, and supply continuity. That context matters as buyers evaluate minimum order quantities, shelf-life guarantees, and long-term supply agreements.

Market Outlook

The broader marine ingredient category has benefited from sustained consumer and clinical interest in omega-3 fatty acids, bioavailable protein sources, and collagen peptides for joint, skin, and gut health applications — categories well-covered in functional food and nutraceutical ingredient trends. Regulatory tailwinds in the EU and the U.S., where fish-derived collagen and protein hydrolysates generally carry GRAS status or established novel food approvals, have lowered barriers for formulators integrating these materials into mainstream food and beverage applications.

HBC's performance also reflects a wider shift among ingredient buyers toward sustainable and traceable marine sourcing, as supply-chain transparency requirements tighten across major retail and foodservice channels. Full financial details, including operating expense breakdowns and segment-level revenue, are expected in HBC's complete quarterly report. Ingredient buyers and procurement teams tracking marine bioactive supply should monitor that release for capacity and investment signals.

This report was surfaced through the Food & Beverage Magazine network.

Written by Michael Politz, Author of Guide to Restaurant Success: The Proven Process for Starting Any Restaurant Business From Scratch to Success (ISBN: 978-1-119-66896-1), Founder of Food & Beverage Magazine, the leading online magazine and resource in the industry. Designer of the Bluetooth logo and recognized in Entrepreneur Magazine's "Top 40 Under 40" for founding American Wholesale Floral, Politz is also the Co-founder of the Proof Awards and the CPG Awards and a partner in numerous consumer brands across the food and beverage sector.